Wilmot Cancer Institute / Research / Clinical Trials

Wilmot Cancer Institute Clinical Trials

Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients.

If you volunteer to enroll in a trial, you are not only helping to improve cancer care – but the trial might also be the best option for your own case. Wilmot offers more than 200 clinical trials with new strategies for treatment, management of side effects, diagnosis, and prevention of cancer. We encourage you to ask us about this option. Whatever you decide, your Wilmot team will ensure that you get the best care possible. Find resources for specific cancers here.

You can search for all studies that are currently enrolling participants at the University of Rochester by typing in keywords in the box below. If you don’t find a study that interests you right now, consider signing up for our Volunteer Registry, which will notify you of future studies.

View Cancer Clinical Trials and Research Studies

What is a Clinical Trial?

Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients.

For Referring Physicians

Reach out to our Wilmot Clinical Trials Office leadership team.

Stories

Read about the people, teamwork, and leadership at the Clinical Trials Office.

Patient Experiences

Alan Brandon

Multiple Myeloma

There’s a misconception that, when a cancer patient is offered a clinical trial, the end is near. But multiple myeloma survivor Alan Brandon is living proof dispelling that notion.

When first diagnosed with multiple myeloma, doctors gave him two to six years to live. That was in 2003, more than 18 years ago.

Thanks to clinical trials, he’s still here. He’s gotten more time with his wife to travel the world, before the pandemic hit. They’ve been to Europe, New Zealand, Mexico and multiple national parks. They even took a nine-country cruise in the Caribbean islands a few years ago.

“I’ve had no limitations with my life,” he says.

Brandon credits that success to clinical trials, having enrolled in a few since coming to Wilmot Cancer Institute for care almost two decades ago. He’s also grateful for the clinical trials volunteers who came before him, allowing treatment to advance by the time he needed it.

“I received treatments where other people proved that the drugs were effective and so it’s not just my experience about trials,” he says. “It’s other peoples’ experiences and I benefitted from that.”